Skip to content
  • The Journal of Bone & Joint Surgery
logo

OrthoBuzz

Keeping you up-to-date with orthopaedic news

  • Features
    • Author 360
    • Diversity, Equity, Inclusion, and Accessibility
    • Inside JBJS
    • Journal Club
    • Need to Know
    • JBJS Press Releases
  • By Subspecialty
    • Basic Science
    • Elbow
    • Foot and Ankle
    • Hand and Wrist
    • Hip
    • Knee
    • Shoulder
    • Spine
    • Infection
    • Oncology
    • Pain Management
    • Pediatrics
    • Rehabilitation
    • Sports Medicine
    • Trauma
  • Editor’s Choice
  • Resident Roundup
  • Specialty Updates
  • About

Month: September 2023

  • Home
  • 2023
  • September
  • Page 2
Editor's Choice Hip Knee

COVID-19 Diagnosis and the Risk of Complications and Mortality After TJA

September 14, 2023September 12, 2023 OrthoBuzz for Surgeons

JBJS Deputy Editor for Social Media Dr. Matt Schmitz reflects on a new study evaluating postoperative complications and mortality in patients who had a recent

Read More
JBJS Press Releases

Common blood pressure medications linked to lower risk of total knee replacement

September 11, 2023September 11, 2023 OrthoBuzz for Surgeons

Patients using beta-blockers are less likely to undergo knee arthroplasty, reports Journal of Bone & Joint Surgery September 7, 2023 – Among patients with knee

Read More
DEIA Editorial Education and Training JBJS OA

DEI Scholarship: New Editorial and Research in JBJS Open Access

September 8, 2023September 8, 2023 OrthoBuzz for Surgeons

In a new editorial, Dr. George Dyer, Deputy Editor of the AOA Critical Issues in Education section of JBJS Open Access, reflects on diversity, equity,

Read More
Shaded world map depicting geographic distribution of participant country of residence and income level.
Editor's Choice Pediatrics

Expanding Opportunities for Educational Advancement in Pediatric Orthopaedic Surgery

September 5, 2023August 31, 2023 OrthoBuzz for Surgeons

Collaborative efforts to provide international educational opportunities have been part of the orthopaedic landscape for many years. Some of these experiences involve orthopaedic society-funded traveling

Read More
Graphs depicting absolute change (mean ± SEM) in LS, FN, and TH BMD during denosumab treatment and after receiving no subsequent therapy or received subsequent treatment with risedronate, alendronate, or zoledronic acid. From "Bone loss after denosumab discontinuation is prevented by alendronate and zoledronic acid but not risedronate: a retrospective study."
Hip Knee Spine Trauma What's New

What’s New in Osteoporosis and Fragility Fractures 2023

September 1, 2023August 30, 2023 OrthoBuzz for Surgeons

Vitamin D supplementation, fracture risk, and osteoporosis drug therapies are among several topics explored in recent studies featured in the new JBJS Guest Editorial: What’s

Read More

Posts pagination

Previous 1 2

Subscribe to OrthoBuzz

JBJS Video Archive

About OrthoBuzz

Recent Posts

  • Multicenter Case Study: Can JBJS Clinical Classroom Boost Resident OITE Scores?
  • What’s New in Adult Reconstructive Knee Surgery 2026
  • Q&A with Dr. Matt Schmitz, JBJS Senior Editor for Pediatrics and Social Media
  • What’s New in Musculoskeletal Basic Science 2025
  • Medical Malpractice in Orthopaedics: Why Awareness, Prevention, and Advocacy Matter

Recent Comments

  • OrthoBuzz for Surgeons on Multicenter Case Study: Can JBJS Clinical Classroom Boost Resident OITE Scores?
  • Thomas Cadier on Multicenter Case Study: Can JBJS Clinical Classroom Boost Resident OITE Scores?
  • Anonymous on Go with the Flow, or Follow the Evidence?
  • Anonymous on Go with the Flow, or Follow the Evidence?
  • Anonymous on What Is the Point of This Piece?
All Rights Reserved 2026. JBJS.org
 

Loading Comments...